Aggregated
28% success rate- Bullish
- 0
- Hold
- 3
- Bearish
- 0
Baird
A Baird analyst with 35 tracked ratings across 23 distinct tickers has a 29.2% success rate on the captured sample, covering both sources.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| SYRE | 2026-04-14 | buy | $90.00 | Aggregated |
| CLYM | 2026-03-06 | buy | $12.00 | Aggregated |
| ARGX | 2026-02-27 | hold | $867.00 | Aggregated |
| ARGX | 2025-12-18 | hold | $858.00 | Aggregated |
| NUVL | 2025-11-18 | buy | $158.00 | Aggregated |
| NUVLNUVALENT INC - ORDINARY SHARES - CLASS A | 2025-11-18 | unknown | $158.00 | Aggregated |
| COGT | 2025-11-11 | hold | $34.00 | Aggregated |
| COGTCOGENT BIOSCIENCES INC | 2025-11-11 | hold | $34.00 | Aggregated |
| APLS | 2025-10-31 | buy | $52.00 | Aggregated |
| OCUL | 2025-10-03 | buy | $24.00 | Aggregated |
| CLYM | 2025-08-15 | buy | $9.00 | Aggregated |
| APLS | 2025-07-18 | buy | $50.00 | Aggregated |
| NUVL | 2025-06-25 | buy | $112.00 | Aggregated |
| NUVLNUVALENT INC - ORDINARY SHARES - CLASS A | 2025-06-25 | unknown | $112.00 | Aggregated |
| ELVN | 2025-06-16 | buy | $52.00 | Aggregated |
| ELVNENLIVEN THERAPEUTICS INC | 2025-06-16 | unknown | $52.00 | Aggregated |
| AGEN | 2025-06-04 | hold | $6.00 | Aggregated |
| AGENAGENUS INC | 2025-06-04 | hold | $6.00 | Aggregated |
| AGEN | 2025-05-13 | hold | $4.00 | Aggregated |
| APLS | 2025-05-08 | buy | $47.00 | Aggregated |
| AGEN | 2025-03-12 | hold | $3.00 | Aggregated |
| CHRS | 2024-12-05 | buy | $6.00 | Aggregated |
| CHRSCOHERUS BIOSCIENCES INC | 2024-12-05 | unknown | $6.00 | Aggregated |
| ELVN | 2024-11-15 | buy | $40.00 | Aggregated |
| SYRE | 2024-11-13 | buy | $65.00 | Aggregated |
| SYRESPYRE THERAPEUTICS INC. | 2024-11-13 | unknown | $65.00 | Aggregated |
| CHRS | 2024-11-08 | buy | $4.00 | Aggregated |
| APLS | 2024-11-07 | buy | $55.00 | Aggregated |
| APLSAPELLIS PHARMACEUTICALS INC | 2024-11-07 | unknown | $55.00 | Aggregated |
| MRSNMERSANA THERAPEUTICS INC | 2024-08-14 | hold | $3.00 | Aggregated |
| CHRS | 2024-07-01 | buy | $8.00 | Aggregated |
| ELVN | 2024-06-11 | buy | $32.00 | Aggregated |
| OCSOCULIS HOLDING AG | 2024-06-11 | unknown | $37.00 | Aggregated |
| ORICORIC PHARMACEUTICALS INC | 2024-03-12 | unknown | $25.00 | Aggregated |
| CHRS | 2024-01-23 | buy | $9.00 | Aggregated |
| CHRS | 2023-11-17 | buy | $11.00 | Aggregated |
| OCULOCULAR THERAPEUTIX INC | 2023-09-14 | unknown | $18.00 | Aggregated |
| IOVAIOVANCE BIOTHERAPEUTICS INC | 2022-04-07 | unknown | $34.00 | Aggregated |
| SABSSAB BIOTHERAPEUTICS INC | 2021-11-02 | unknown | $23.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| SYRE | 2 | 2026-04-14 | Aggregated |
| CLYM | 2 | 2026-03-06 | Aggregated |
| ARGX | 2 | 2026-02-27 | Aggregated |
| NUVL | 2 | 2025-11-18 | Aggregated |
| NUVLNUVALENT INC - ORDINARY SHARES - CLASS A | 2 | 2025-11-18 | Aggregated |
| COGT | 1 | 2025-11-11 | Aggregated |
| COGTCOGENT BIOSCIENCES INC | 1 | 2025-11-11 | Aggregated |
| APLS | 4 | 2025-10-31 | Aggregated |
| OCUL | 1 | 2025-10-03 | Aggregated |
| ELVN | 3 | 2025-06-16 | Aggregated |
| ELVNENLIVEN THERAPEUTICS INC | 1 | 2025-06-16 | Aggregated |
| AGEN | 3 | 2025-06-04 | Aggregated |
| AGENAGENUS INC | 1 | 2025-06-04 | Aggregated |
| CHRS | 5 | 2024-12-05 | Aggregated |
| CHRSCOHERUS BIOSCIENCES INC | 1 | 2024-12-05 | Aggregated |
| SYRESPYRE THERAPEUTICS INC. | 1 | 2024-11-13 | Aggregated |
| APLSAPELLIS PHARMACEUTICALS INC | 1 | 2024-11-07 | Aggregated |
| MRSNMERSANA THERAPEUTICS INC | 1 | 2024-08-14 | Aggregated |
| OCSOCULIS HOLDING AG | 1 | 2024-06-11 | Aggregated |
| ORICORIC PHARMACEUTICALS INC | 1 | 2024-03-12 | Aggregated |
| OCULOCULAR THERAPEUTIX INC | 1 | 2023-09-14 | Aggregated |
| IOVAIOVANCE BIOTHERAPEUTICS INC | 1 | 2022-04-07 | Aggregated |
| SABSSAB BIOTHERAPEUTICS INC | 1 | 2021-11-02 | Aggregated |